MET-233I
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Pfizer · Phase 1/2 · Completed · Enrollment 201
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Part A Cohort | n/r | n/r | n/r | n/r |
| Part B Cohort | n/r | n/r | n/r | n/r |
| Part C Cohort | n/r | n/r | n/r | n/r |
| Part D Cohort | n/r | n/r | n/r | n/r |
| Part E Cohort | n/r | n/r | n/r | n/r |
| Part G Cohort | n/r | n/r | n/r | n/r |
Not shown
- Part A Cohort: endpoint not reported
- Part B Cohort: endpoint not reported
- Part C Cohort: endpoint not reported
- Part D Cohort: endpoint not reported
- Part E Cohort: endpoint not reported
- Part G Cohort: endpoint not reported